Pharma Point on behalf of Oncopeptides is seeking, for the Italian affiliate, a Senior KAM Hematology
– Lombardia/Trentino Alto Adige (Milan based).

Our client, ONCOPEPTIDES AB (PUBL), is a biotech company focused on research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells.

The product has been granted Marketing Authorization in the European Union, the EEA countries Iceland, Liechtenstein and Norway, as well as in the UK. It is indicated in combination with dexamethasone for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-CD38 monoclonal antibody, and who have demonstrated disease progre...